At Adello, our vision is to provide high-quality, affordable #biosimilars to patients worldwide.

Picataway, NJ
Joined October 2014
FDA Accepts Adello’s #Biosimilar Biologics License Application for a Proposed Filgrastim Biosimilar #biosimilars adellobio.com/news/2017/fda-…
Our CEO speaks about Adello's singular focus on #biosimilars and building a company culture from the bottom up. biosimilardevelopment.com/do…
1
2
We're pleased to announce our new name and identity: Adello Biologics. This change reflects an exciting step in the evolution of our company
1
1
We're happy to welcome our new Chief Scientific Officer, Dr. Michael W. Washabaugh, to the TPI family businesswire.com/news/home/2…
3
Biosimilars are helping to make #healthcare more affordable. Learn more about #biosimilars on our website: theraproteins.com/about-bios…
2
3
We're happy to welcome our new CEO, Dr. Peter Moesta, to the TPI family. Read more: theraproteins.com/news/